The treatment of gastrointestinal stromal tumor with imatinib lead to hyperplasia of keloid

doi:10.3877/cma.j.issn.2095-3224.2019.03.019

Abstract

Abstract:

Imatinib mesylate is a selective tyrosine kinase inhibitor that inhibits the tyrosine kinase of bcr-abl, PDGF receptor, SCF, c-kit and other receptors at the cellular level. It Inhibits cell proliferation and induces apoptosis. Imatinib is the first-line drug for the treatment of gastrointestinal stromal tumor. The most common adverse reactions of Imatinib are edema, skin rash, fatigue, nausea and neutropenia, But the induction about hyperplasia of keloid in patients has not been reported. This case suggests that imatinib may lead to hyperplasia of skin keloid, possibly by influencing the immune system of patients with gastrointestinal stromal tumor.

Key words: Gastrointestinal stromal tumor, Imatinib, Keloid

Yongjian Zhou, Weijun Zheng, Guosheng Lin. The treatment of gastrointestinal stromal tumor with imatinib lead to hyperplasia of keloid[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2019, 08(03): 301-303.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhjzcjbdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3224.2019.03.019

https://zhjzcjbdzzz.cma-cmc.com.cn/EN/Y2019/V08/I03/301

Figures/Tables 2

References 14

[1]	Mazur MT, Clark HB. Gastric stromal tumors. Reappraisal of histogenesis [J]. Am J Surg Pathol, 1983, 7(6): 507-519.
[2]	金哲虎. 瘢痕疙瘩的成因及治疗新进展[J]. 中国医学文摘(皮肤科学), 2015, 32(1): 11-15+4.
[3]	程飚, 付小兵, 盛志勇. 免疫因素在瘢痕形成和发展中的作用[J]. 中国临床康复, 2002, 6(4): 464-466.
[4]	Harty M, Neff AW, King MW, et al. Regeneration or scarring: an immunologic perspective [J]. Dev Dyn, 2003, 226(2): 268-279.
[5]	Riva G, Luppi M, Barozzi P, et al. Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph＋acute lymphoblastic leukemia during long-term imatinib mesylate treatment [J]. Blood, 2010, 115(8): 1512-1518.
[6]	Siegers GM, Felizardo TC, Mathieson AM, et al. Anti-leukemia activity of in vitro-expanded human gamma delta T cells in a xenogeneic Ph＋leukemia model [J]. PLoS One, 2011, 6(2): e16700.
[7]	Akashi N, Matsumoto I, Tanaka Y, et al. Comparative suppressive effects of tyrosine kinase inhibitors imatinib and nilotinib in models of autoimmune arthritis [J]. Mod Rheumatol, 2011, 21(3): 267-275.
[8]	王欣, 刘泽林, 卢博, 等. 甲磺酸伊马替尼治疗慢性粒细胞白血病的临床效果及其对免疫功能的影响[J].中国当代医药, 2015, 22(9): 77-79.
[9]	陈小华, 邱华云, 施珊珊, 等. 伊马替尼诱导原代T细胞凋亡作用机制研究[J]. 中国免疫学杂志, 2016, 32(9): 1268-1271＋1275.
[10]	Tan Y, Trent JC, Wilky BA, et al. Current status of immunotherapy for gastrointestinal stromal tumor [J]. Cancer Gene Ther, 2017, 24(3): 130.
[11]	闫贵春, 安新, 张海永, 等. 瘢痕患者免疫功能状态研究[J]. 中国美容医学, 2011, 20(2): 247-251.
[12]	莫济贤, 罗少军, 梁杰, 等. 瘢痕疙瘩形成机制的研究进展[J]. 医学综述, 2006, 12(12): 705-706.
[13]	郭雷洋, 曹莫. 瘢痕疙瘩发病机制的研究进展[J]. 中国美容医学, 2012, 21(11): 1674-1677.
[14]	Delahaye NF, Rusakiewicz S, Martins I, et al. Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors [J]. Nat Med, 2011, 17(6): 700-707.

[1]	Yaping Li, Mingjie Zhu, Hongyuan Jiang. Pathological characteristics and prognosis of high risk gastrointestinal stromal tumors [J]. Chinese Archives of General Surgery(Electronic Edition), 2020, 14(03): 222-225.
[2]	Youchun Sheng, Qiang Zhang, Ming Chen, Kangjing Xu, Hao Xu. Role of intracellular imatinib concentration in drug resistance of gastrointestinal stromal tumor [J]. Chinese Archives of General Surgery(Electronic Edition), 2020, 14(02): 84-88.
[3]	. Radical resection of a rare giant gastrointestinal stromal tumor [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(02): 235-236.
[4]	Chen Lin, Meng Wang, Wenxian Guan, Feng Wang. Advances in immunotherapy and new strategies for gastrointestinal stromal tumor [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(01): 98-100.
[5]	Peijie Liu. Prognosis and safety analysis of double mirror combined therapy for gastric stromal tumor [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2022, 16(01): 107-110.
[6]	Feng Wang, Heng Yu, Meng Wang, Wenxian Guan. Prognosis analysis of patients with intermediate and high risk gastrointestinal stromal tumor after surgery [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2021, 15(04): 460-463.
[7]	Zhiyi Cheng, Xiaojun Zhao, Xiaolan You, Chuanjiang Huang, Guiyuan Liu, Xunan Mao. Comparative analysis of the clinical effect of laparoscopic gastric wedge resection and transumbilical laparoendoscopic single site gastric wedge resection [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2020, 14(05): 495-498.
[8]	Heng Yu, Shangce Du, En Xu, Xingzhou Wang, Xuefeng Xia, Lei Su, Feng Wang, Wenxian Guan. Research progress on prognostic factors of gastrointestinal stromal tumor [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2020, 14(01): 97-100.
[9]	Gang Yin, Zhipeng Sun, Peirong Tian, A min bu he, Tianxiong Li. Single-center retrospective analysis of laparoscopic resection of gastrointestinal stromal tumor [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2020, 14(01): 70-73.
[10]	Dafu Zhang, Youguo Dai, Guangjun Yang, Zhiping Zhang, Zhenhui Li. The differential diagnosis of mesenteric invasive fibromatosis and gastrointestinal stromal tumor based on CT enhancement [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2020, 09(06): 597-604.
[11]	Xueshan Bai, Guole Lin, Xin Wu, Xiaoqiang Xue, Jiaolin Zhou, Huizhong Qiu. Transanal endoscopic microsurgery (TEM) for rare rectal tumors [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2019, 08(06): 580-587.
[12]	Xiaopeng Shen, Dong Li. Progress in scar prevention and treatment [J]. Chinese Journal of Clinicians(Electronic Edition), 2019, 13(06): 463-467.
[13]	Fulai Gao, Dongqiang Zhao. Research progress of long noncoding RNA in gastrointestinal stromal tumor [J]. Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition), 2022, 09(03): 152-155.
[14]	Chunyan Zou, Dongqiang Zhao. Research progress on the role and mechanism of circular RNA in gastrointestinal stromal tumors [J]. Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition), 2021, 08(04): 179-181.
[15]	Paerhatijiang·Abulimiti, Duolikun·Yasheng, Kelimu·Abudureyimu, . Ababokeli·Wusiman. Current status and progression of immunotherapy for gastrointestinal stromal tumor [J]. Chinese Journal of Gastroesophageal Reflux Disease(Electronic Edition), 2020, 07(01): 64-67.

Please choose a citation manager

Content to export